Company Description
The onus is on SONUS Pharmaceuticals to get drugs into patients more effectively. The firm has developed the TOCOSOL drug delivery technology, a...
Key Sonus Pharmaceuticals Financials
| Company Type | Public - NASDAQ (GM): SNUS Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $20.1 |
| 2005 Employees | 48 |
More Sonus Pharmaceuticals Financials (11 pages)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Sonus Pharmaceuticals's competition across multiple industries
Top Sonus Pharmaceuticals Competitors
Sponsored Links
The Business Directory
Sonus Pharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Robert E. Ivy | Network | E-mail |
| President, CEO, and Director | Michael A. Martino | Network | E-mail |
| SVP and CFO | Alan Fuhrman | Network | E-mail |
More Sonus Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Sonus Pharmaceuticals News
- BioWorld Today May 12, 2008 [BioWorld Today] (12 May 2008 00:01:00 EDT)
-
Sonus Pharmaceuticals Inc. (NASD:SNUS) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 02:45:00 EDT) - SNUS: Receives Nasdaq Delisting Notice [Knobias.com] (09 May 2008 08:58:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.